Viewing Study NCT03324932


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-06-17 @ 7:35 PM
Study NCT ID: NCT03324932
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-10-06
First Post: 2017-09-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer
Sponsor: Kyoto Prefectural University of Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bone health View
None hormone-sensitive breast cancer View
None postmenopausal View
None aromatase inhibitor View
None bone mineral density View